Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent

被引：51
|
作者：
Li, Jingjing [1 ]
Guo, Chuanyong [2 ]
Wu, Jianye [1 ]
机构：
[1] Tongji Univ, Putuo Peoples Hosp, Dept Gastroenterol, Sch Med, Shanghai 200060, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Sch Med, Shanghai 200072, Peoples R China
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2020年 / 14卷
关键词：
astaxanthin; liver diseases; antioxidants; inflammation; anticancer; HEPATIC STELLATE CELLS; DIET-INDUCED OBESITY; OXIDATIVE STRESS; PPAR-GAMMA; INHIBITS PROLIFERATION; SUBCHRONIC TOXICITY; CAROTENOIDS; APOPTOSIS; INJURY; MICE;
D O I：
10.2147/DDDT.S230749
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Astaxanthin is a carotenoid derived from oxygen-containing non-vitamin A sources and is mainly obtained from marine organisms. Studies have demonstrated that astaxanthin is a natural antioxidant product and it is widely used in the fields of medicine, health-care products and cosmetics. Studies have shown that astaxanthin has important preventive and therapeutic effects on liver fibrosis, non-alcoholic fatty liver, liver cancer, drug and ischemia-induced liver injury, and its mechanism is related to antioxidant and anti-inflammatory activities, and the regulation of multiple signaling pathways. In this review, we discuss the latest data on astaxanthin in the prevention and treatment of liver diseases. An understanding of the structure, source and mechanism of action of astaxanthin in the body would not only provide a theoretical basis for its clinical application but could also have important significance in screening and improving related compounds for the treatment of liver diseases.
引用
收藏
页码：2275 / 2285
页数：11
相关论文
共 50 条
  • [41] Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
    Szabo, Gyongyi
    Momen-Heravi, Fatemeh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (08) : 455 - 466
  • [42] Therapeutic potential of green tea in nonalcoholic fatty liver disease
    Masterjohn, Christopher
    Bruno, Richard S.
    NUTRITION REVIEWS, 2012, 70 (01) : 41 - 56
  • [43] Aerobic exercise: a potential therapeutic intervention for patients with liver disease
    Bergasa, NV
    Mehlman, J
    Bir, K
    MEDICAL HYPOTHESES, 2004, 62 (06) : 935 - 941
  • [44] Astaxanthin impact on brain: health potential and market perspective
    Cunha, Sara A.
    Borges, Sandra
    Baptista-Silva, Sara
    Ribeiro, Tania
    Oliveira-Silva, Patricia
    Pintado, Manuela
    Batista, Patricia
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (30) : 11067 - 11090
  • [45] Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent
    Barros, Priscila O.
    Berthoud, Tamara K.
    Aloufi, Nawaf
    Angel, Jonathan B.
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 47 - 62
  • [46] Hepatic β-arrestins: potential roles in liver health and disease
    Eissa, Alzahraa Muhammad
    Hassanin, Mohamed H.
    Ibrahim, Islam A. A. E. H.
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (12) : 10399 - 10407
  • [47] Hepatic β-arrestins: potential roles in liver health and disease
    Alzahraa Muhammad Eissa
    Mohamed H. Hassanin
    Islam A. A. E. H. Ibrahim
    Molecular Biology Reports, 2023, 50 : 10399 - 10407
  • [48] Exploring the therapeutic potential of liver-targeted interleukin 22 in fatty liver disease
    Sajiir, H.
    Keshvari, S.
    Wong, K. Y.
    Fotheringham, A.
    Wang, R.
    Wiid, P.
    Lockett, J.
    Macdonald, G.
    Prins, J.
    McGuckin, M. A.
    Hasnain, S. Z.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 32 - 33
  • [49] Plasma membrane integrity in health and disease: significance and therapeutic potential
    Catarina Dias
    Jesper Nylandsted
    Cell Discovery, 7
  • [50] Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential
    Thomas G. Martin
    Miranda A. Juarros
    Leslie A. Leinwand
    Nature Reviews Cardiology, 2023, 20 : 347 - 363
12345